Higharc, Inc. is a technology company based in Durham, North Carolina, founded in 2018. It offers a comprehensive web platform designed for homebuilders and new homebuyers, focusing on three-dimensional home design and customization. The platform allows users to create tailored home designs while managing plans, standards, and options within a single interface. It provides accurate materials lists and generates permit-ready construction documents, streamlining the building process. By enabling builders to design and sell homes in 3D, Higharc aims to enhance the efficiency of design, construction, and sales, ultimately reducing material waste and costly errors. The company's mission is to support builders in creating high-quality homes and communities in a more affordable manner.
Hyphen
Funding Round in 2022
Hyphen specializes in automating culinary operations for the restaurant and foodservice industry. The company develops a food technology solution aimed at reducing the cost of fresh food through the use of robotics. Their technology features modular hardware and reprogrammable software, which employs computer vision technology to assist restaurants in managing peak hours during lunch and dinner, while also preventing human errors in food preparation.
Anduril Industries
Series E in 2022
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Renata Medical
Series B in 2022
Renata Medical is a company dedicated to developing innovative medical devices aimed at addressing the needs of children born with congenital heart disease (CHD). The company focuses on creating solutions that are both safe and versatile, specifically targeting unmet congenital needs in pediatric healthcare. One of its key products is an adjustable stent designed to be inserted at birth, which grows with the child, thereby reducing the necessity for multiple invasive surgeries over time. This approach not only enhances the quality of care for congenital patients but also minimizes the associated costs and risks of ongoing surgical interventions.
Slingshot Aerospace
Series A in 2021
Slingshot Aerospace, Inc. is a technology company that develops online tools and platforms to provide geospatial information for the aerospace and defense industries. With its suite of platforms, including Slingshot Earth, Slingshot Orbital, Slingshot Edge, and Slingshot Imagery, the company integrates data streams from various sources, such as satellites, drones, and ground-based sensors, to deliver critical insights that enhance decision-making for its clients. Operating from its headquarters in El Segundo, California, and an additional office in Austin, Texas, Slingshot Aerospace serves a diverse range of sectors, including energy, aerospace, insurance, military, government, engineering services, and emergency management. The company's mission is to empower both government and commercial space organizations by providing simulation and analytics solutions that improve mission success and ensure safe, reliable operations in complex environments.
Sydnexis is a biopharmaceutical company focused on developing a proprietary treatment for pediatric progressive myopia, which represents a significant unmet medical need globally. The company specializes in manufacturing a topical eyedrop formulation aimed at slowing the progression of myopia in children. By providing an innovative solution, Sydnexis enables healthcare professionals and institutions to effectively manage and reduce the incidence of myopia-related eye disorders in the pediatric population.
Renata Medical
Series A in 2020
Renata Medical is a company dedicated to developing innovative medical devices aimed at addressing the needs of children born with congenital heart disease (CHD). The company focuses on creating solutions that are both safe and versatile, specifically targeting unmet congenital needs in pediatric healthcare. One of its key products is an adjustable stent designed to be inserted at birth, which grows with the child, thereby reducing the necessity for multiple invasive surgeries over time. This approach not only enhances the quality of care for congenital patients but also minimizes the associated costs and risks of ongoing surgical interventions.